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The paper reports successful thrombolysis conducted in 64 years old woman admitted to the clinic with
clinical and angiographic data for acute surgical abdomen caused by acute tromboembolia of arteria
mesenterica superior (AMS). The therapeutic approach required to undertake lifesaving decision on i.e.
surgical vs. invasive treatment in conditions of emergency. Finally, it was decided to undertake invasive
treatment with successful restoration of blood ﬂow in the related artery. The patient was discharged
from the clinic with considerable clinical improvement on the ﬁfth day of her stay. The case report in-
cludes discussion on issues relating the consequence of the diagnostic and interventional procedures in
such patients, opportunities for conducting emergency thrombolysis in acute embolia of AMS and pre-
ventive measures in patients with high tromboembolic risk.
Copyright © 2016 The Emergency Medicine Association of Turkey. Production and hosting by Elsevier
B.V. on behalf of the Owner. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Acute mesenteric ischemia remains a diagnostic and thera-
peutic challenge. Mortality is high and ranges between 50.0 and
97.3%. Angiography is the keystone of the diagnosis and treatment.
Early aggressive therapy allows decreasing mortality rate up to
about 30%. Various techniques are used to restore the blood ﬂow
including selective thrombolysis, angioplasty or bypass surgery or
the combination of these techniques. Thrombolysis has been
described as a stand-alone treatment for acute occlusion of AMS,
with good outcome but is relatively rare. In a recent publication,
thrombolysis has been described as a useful adjunct to endovas-
cular embolectomy in order to remove residual clotting.1,2
We present a case of early-diagnosed thromboembolia of AMS
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64 years old woman was admitted in the surgical clinic with
complains of abdominal pain lasting approximately twelve hours
after last meal with sustained attacks and multiple vomiting. She
has reported a single defecation in the last twenty-four hours. She
has also had palpitation and oppression in the heart region. Past
diseases include history of rheumatic heart disease with a
considerable mitral stenosis. She has also undergone balloon an-
gioplasty of mitral valve.
Ten days ago she was treated for acute thrombosis of the right
arteria poplitea in the vascular surgery ward of other hospital with
Enoxiparin 0.6 ml 1 time daily with full resolution of her com-
plaints. Clinical examination established a slightly impaired gen-
eral status. Skin and visible mucous membranes were pale with
moist and slightly coated tongue. Bone and muscle system were
properly developed and patient had normal Height 160 cm,
Weight 72 kg (Body mass index 28.1 kg/cm2). The lung ausculta-
tion revealed vesicular bilateral breathing weakened slightly in the
right base. Respiratory rate on admission was 20 per minute. On
admission was detected arrhythmia with pulse rate of 96 beats/
min and blood pressure 140/80 mmHg. Heart sounds were clearly
heard but the second heart sound was accentuated and widelyn and hosting by Elsevier B.V. on behalf of the Owner. This is an open access article
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tated. Abdomen was painful below the chest, respiratory movable,
unbloating. The abdominal walls were soft and elastic, allowing
deep palpation without peritoneal irritation. The intestinal
motility was dull without intestinal gurgling. Rectal Touche
revealed empty ampoule.
Electrocardiography (ECG) conﬁrmed atrial ﬁbrillation.
Echocardiography hasn't recognized an intra-cardiac thrombus.
Radiography presented small pleural effusion, notably extended
arc of the left ventricle in cardiac conﬁguration corresponding to
the mitral stenosis. The X-ray of the abdomen made visible 1e2
hydro-aeric shadows in the small bowel.
Ultrasonography of the abdomen (done on the ﬁrst hour of
hospitalization) revealed visible a part of the bowel loops with
thickened hypo echogenic wall with size of 8 mm on the left side of
the abdomen, enlarged lymph nodes in the neighborhood. Doppler
program does not detect acoustic window. Small amounts of free-
ﬂowing liquid in the pelvis were also detected.
The angiography (done on the second hour of admission and
exploring the aorta and branches with intravenous application of
the contrast) visualized thrombus and mural ﬁlling defect in AMS
at the level of vena lienalis that is followed by the total occlusion
and lack of contrast in it (Fig. 1).
Laboratory investigations: Leukocytes e 28.0/l, prothrombin
time (sec.) e 24.7 s; Prothrombin time (%) e 82%; International
normalized ration (INR) e 2.14.
Summarizing the clinical, instrumental and laboratory data on
the 4th hour after the patient was admitted; it was decided to
undertake selective angiography of AMS with conducting intra-
arterial thrombolysis.
Catheterization investigation protocol included: body surface
area of 1.78 m2; access from the right radial artery; used contrast
Ultravist 220 ml, time of investigation of 45 min. Angiography
revealed acute thrombosis of AMS. Coronary arteries were without
signiﬁcant stenosis.
The patient was treated with thrombolysis done with 10 mg
bolus Alteplase, applied directly in AMS, followed by intra-arterial
infusion over 30 min. In the next 1 h and 30 min was done the
intravenous infusion of the remaining 50 ml of the thrombolytic.Fig. 1. Total occlusion of a. mesenterica sup.The sheet was left for conducting a control invasive investigation
done three hours after the ﬁrst. The control investigation estab-
lished a total lysis of the related thrombus, restored blood ﬂow in
the artery with residual mural thrombi (Figs. 2 and 3).
The follow up showed gradual attenuation of the acute
abdominal symptoms. The control of coagulation status showed
that the prothrombin time was 71%e9.40 s, ﬁbrinogen 3.48 g/l,
partial thromboplastin time (aPPT) e 32 s, INR e 1.0.
It is also important to notice that the control laboratory in-
vestigations were taken while the patient was treated with Hep-
arin in doses 25,000 E e 50 ml (1.7 ml/h). Control of aPTT was
conducted twice daily. The patient was given the ﬁrst meal on the
second day. The intestinal passage and asymptomatic state were
detected on the on the third day. On the ﬁfth day control blood
parameters reached the normal values and the patient was dis-
charged from the Clinic with prescription for anti aggregation
therapy as prevention.3. Discussion
Acute disorders of mesenteric circulation proceed in three main
consecutive stages including ischemia, infarction (necrosis) of the
bowel and peritonitis. Only the ﬁrst stage is reversible. The other
two stages are irreversible. Acute mesenteric thromboembolism,
the most common manifestation of acute intestinal ischemia is
characterized by complete or almost complete stop of the arterial
supply towards the intestinal wall. As a consequence of that pro-
cesses the toxic products of incomplete metabolism are accumu-
lated in the bowel wall. Initially, the toxic products do not enter
blood and do not cause toxicity but only in that early stage of the
disease, which makes the promptness of the diagnostic and ther-
apeutic measures in patients with thrombosis of AMS crucial.3,4
Early diagnosis is also of great importance for better prog-
nosis.5,6 Embolism is the most common cause of the disorders of
the mesenteric ﬂow. Embolism of the AMS occurs more frequently
than the embolism of lower mesenterial artery due to the sharp
angle between the artery and the aorta. The mesenteric artery
thromboembolism is generally related to the co-existing heartFig. 2. Initial partial recovery of blood ﬂow at 45 min.
Fig. 3. Recovered blood ﬂow after the third hour.
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diseases of the aortic wall. Sometimes the thromboembolia of AMS
could be also caused by “paradoxical embolism” from thrombus of
venous origin in patients with congenital diseases with abnormal
opening between the left and right chambers of the heart.6e8
Early clinical signs of acute bowel ischemia are not of speciﬁc.
The main symptom is abdominal ischemic pain. The diagnosis is
based on history and clinical presentation, ultrasound, angiog-
raphy, CAT, Magnetic Resonance Imaging, laparoscopy. The “gold
standard” for the diagnosis remains, however, the selective
mesenteric angiography. Angiography helps also physicians to
specify the type of the disorder, level of occlusion, localization and
stage of the disease.3,5,6,9
Until recently surgical methods, resection and/or vascular sur-
gery (embolectomy) in combination with anticoagulant therapy
were the main therapeutic approaches. Recently the ﬁbrinolytic
(thrombolytic) therapy was introduced as a therapeutic option as
well. Reports on the successful early ﬁbrinolytic treatment of acute
mesenteric embolism have been known since several years and are
sparse so far. There is a technique using very low dose thrombolytic
and ultrasonographyc waves to break and clean thrombus. The
therapeutic beneﬁt of ﬁbrinolysis has been well investigated and
experienced in the treatment of themost signiﬁcant manifestations
of thromboembolic disease i.e. coronary, cerebrovascular embolic
events as well as other potential areas like deep venous thrombosis
and pulmonary edema. According the recommendations in the
literature and pharmacological posology, the calculation of the dose
regimen has estimated the physical features of the patient and
his hematological status.8,10 The accepted advantage of the methodis that the thrombolytic agents can be used in different ways e
directly, intra-arterial in the mesenteric artery, through the internal
jugular vein or through the portal circulation.11
4. Conclusion
The presented case is the ﬁrst report of successful ﬁbrinolysis of
acute thromboembolic occlusion of AMS in Bulgaria and one of the
rare such cases in clinical practice, in general. The presented case
demonstrates the potential of the method in acute phase although
the existing sparse reports on such cases in the literature.12
We consider that the good therapeutic result provides a
convincing evidence for the potential of pharmaco-angiographic
procedures. Factors that deﬁne successful outcome include early
stage, correct diagnosis and precisely deﬁned therapeutic protocol.
The application of pharmaco-angiographic procedures provides the
best opportunity for improved survival and prognosis of patients
with acute thromboembolia of AMS.
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